Eric Chang, MD
Nephrology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Yale University School of Medicine, 2018
Offices
1 location · Capital Nephrology Medical Group · 22 clinicians in this group
Looking this up.
Hospitals listed: 552747 · 552802 · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chang’s office at (916) 564-6232 to ask if they take your plan before you enroll.
California Medical Board record
Licence A152903 · Current
Licensed to practise in California · since 2017 · expires 2027-11-30 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$155,001
Medicare paid this office $155,001 for 378 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $52,163 | $235 |
| Home dialysis services per month (20 years or older) | 21 | $23,350 | $238 |
| Critical care, first 30-74 minutes | 31 | $15,858 | $169 |
| Return visit (30+ min) | 118 | $11,135 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $10,981 | $63 |
See all 15 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $52,163 | $235 |
| Home dialysis services per month (20 years or older) | 21 | $23,350 | $238 |
| Critical care, first 30-74 minutes | 31 | $15,858 | $169 |
| Return visit (30+ min) | 118 | $11,135 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $10,981 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $7,250 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $5,328 | $157 |
| Short return visit (20+ min) | 72 | $4,970 | $56 |
| Dialysis services, per day, less than full month service (20 years or older) | 27 | $4,856 | $7 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 178 | $4,804 | $13 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 30 | $3,042 | $51 |
| New patient visit (45+ min) | 28 | $2,917 | $104 |
| New patient visit (30+ min) | 25 | $2,237 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,990 | $105 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $647 | $40 |
Who their Medicare patients are
378 Original Medicare patients in 2024. Average age 71 · Under 65 22% · 85 and older 14% · Women 52% · Also on Medicaid 57% · Health risk score 5.09. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 63% · Heart failure 51% · Coronary heart disease 46% · Atrial fibrillation 34% · Depression 25% · COPD 24% · Cancer 16% · Stroke 15% · Dementia 11%.
The office billed $403,763, Medicare allowed $207,175 and paid $155,001; for 2,260 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 378 | 2,260 | 71 | 5.09 | $403,763 | $155,001 |
| 2023 | 377 | 1,814 | 70 | 4.68 | $382,655 | $151,944 |
| 2022 | 356 | 1,342 | 71 | 4.85 | $346,990 | $142,117 |
| 2021 | 416 | 1,328 | 70 | 4.84 | $379,249 | $165,863 |
| 2020 | 366 | 1,282 | 70 | 4.47 | $411,071 | $160,494 |
| 2019 | 409 | 1,417 | 69 | 5.28 | $434,559 | $162,260 |
| 2018 | 182 | 431 | 69 | 5.25 | $89,002 | $40,715 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $48,604 | $241 |
| Home dialysis services per month (20 years or older) | 20 | $20,590 | $239 |
| Critical care, first 30-74 minutes | 35 | $18,620 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $12,581 | $65 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $10,883 | $170 |
| Return visit (30+ min) | 109 | $9,294 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $8,913 | $98 |
| Dialysis services, per day, less than full month service (20 years or older) | 21 | $5,246 | $8 |
| Short return visit (20+ min) | 54 | $3,564 | $59 |
| New patient visit (45+ min) | 26 | $3,080 | $118 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,485 | $108 |
| New patient visit (30+ min) | 24 | $2,190 | $91 |
| Long return visit (40+ min) | 11 | $914 | $76 |
| Hemodialysis procedure with physician evaluation | 11 | $832 | $55 |
2022: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $61,848 | $243 |
| Home dialysis services per month (20 years or older) | 20 | $17,607 | $232 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $13,851 | $57 |
| Return visit (30+ min) | 97 | $8,805 | $53 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $8,153 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $6,991 | $83 |
| Critical care, first 30-74 minutes | 20 | $5,383 | $174 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,681 | $112 |
| Hemodialysis procedure with physician evaluation | 39 | $3,211 | $61 |
| New patient visit (45+ min) | 23 | $2,851 | $124 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $1,735 | $8 |
| Short return visit (20+ min) | 22 | $1,613 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $242 | $14 |
2021: 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $68,562 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $19,335 | $59 |
| Home dialysis services per month (20 years or older) | 23 | $17,895 | $245 |
| Return visit (30+ min) | 67 | $10,767 | $97 |
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $8,469 | $169 |
| Critical care, first 30-74 minutes | 12 | $7,655 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $6,455 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 53 | $6,219 | $113 |
| Hemodialysis procedure with physician evaluation | 46 | $4,521 | $61 |
| Short return visit (20+ min) | 49 | $3,121 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,001 | $167 |
| New patient visit (45+ min) | 19 | $1,875 | $99 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,846 | $51 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 39 | $1,631 | $32 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,503 | $84 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $627 | $35 |
2020: 10 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 53 | $81,119 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $18,992 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 104 | $12,967 | $116 |
| Return visit (30+ min) | 99 | $10,632 | $72 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 17 | $7,484 | $227 |
| Hemodialysis procedure with physician evaluation | 43 | $5,542 | $62 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $5,512 | $157 |
| New patient visit (45+ min) | 34 | $3,794 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,359 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,472 | $61 |
2019: 10 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 70 | $47,529 | $192 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 60 | $32,738 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 170 | $28,742 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 121 | $14,825 | $110 |
| Return visit (30+ min) | 79 | $13,599 | $83 |
| New patient visit (45+ min) | 48 | $5,966 | $124 |
| Hemodialysis procedure with physician evaluation | 41 | $4,664 | $60 |
| Dialysis services, 1 physician visit per month (20 years or older) | 18 | $3,502 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,946 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,810 | $165 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $9,898 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $8,852 | $192 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 19 | $7,666 | $232 |
| New patient visit (45+ min) | 28 | $3,728 | $133 |
| Return visit (30+ min) | 35 | $3,498 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,776 | $111 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,719 | $32 |
| Hemodialysis procedure with physician evaluation | 13 | $1,185 | $59 |
Medicaid work
$15,195 in 2024
Medicaid paid $15,195 for 888 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 317 | $5,800 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 115 | $4,397 |
| Return visit (30+ min) | 143 | $3,279 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 50 | $945 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $298 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 229 | $250 |
| Short return visit (20+ min) | 17 | $226 |
| 2024 | 888 | 7 | 37 | $15,195 |
| 2023 | 703 | 6 | 36 | $15,107 |
| 2022 | 836 | 9 | 29 | $13,385 |
| 2021 | 836 | 4 | 29 | $14,095 |
| 2020 | 3,421 | 7 | 31 | $13,300 |
| 2019 | 2,050 | 9 | 31 | $9,621 |
| 2018 | 130 | 3 | 16 | $1,700 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 327 | $7,276 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 178 | $3,995 |
| Return visit (30+ min) | 107 | $1,591 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $927 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 34 | $670 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 24 | $647 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 288 | $7,564 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 144 | $2,317 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 118 | $1,833 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $607 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 21 | $476 |
| Return visit (30+ min) | 42 | $407 |
| Injection, doxercalciferol, 1 mcg | 51 | $93 |
| Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40 | $88 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 116 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 298 | $10,914 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 235 | $3,053 |
| Return visit (30+ min) | 28 | $128 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 275 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 316 | $9,650 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 59 | $952 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 15 | $931 |
| Return visit (30+ min) | 78 | $824 |
| Iron sucrose injection | 258 | $801 |
| Injection, doxercalciferol, 1 mcg | 298 | $143 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,397 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 132 | $3,359 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 96 | $2,879 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 94 | $1,376 |
| Iron sucrose injection | 240 | $1,201 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $552 |
| Return visit (30+ min) | 14 | $148 |
| Injection, doxercalciferol, 1 mcg | 159 | $105 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,287 | $0 |
| Administration of influenza virus vaccine | 14 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 98 | $1,269 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 16 | $380 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 16 | $51 |
Drugs they prescribed that Part D paid
$268,296
Pharmacies billed $268,296 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,245) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,130 generic and 115 brand-name prescriptions · $268,296 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 18 | $110,261 | $6,126 |
| Lokelma | 26 | $28,876 | $1,111 |
| Sevelamer Carbonate | 46 | $22,095 | $480 |
| Auryxia | 12 | $14,713 | $1,226 |
| Calcium Acetate | 75 | $8,334 | $111 |
See all 21 drugs
| Velphoro | 18 | $110,261 | $6,126 |
| Lokelma | 26 | $28,876 | $1,111 |
| Sevelamer Carbonate | 46 | $22,095 | $480 |
| Auryxia | 12 | $14,713 | $1,226 |
| Calcium Acetate | 75 | $8,334 | $111 |
| Calcitriol | 128 | $3,487 | $27 |
| Losartan | 165 | $1,351 | $8 |
| Nifedipine Er | 29 | $1,320 | $46 |
| Hydralazine | 71 | $907 | $13 |
| Furosemide | 133 | $880 | $7 |
| Metoprolol | 26 | $686 | $26 |
| Amlodipine Besylate | 95 | $651 | $7 |
| Lisinopril | 55 | $349 | $6 |
| Prednisone | 32 | $340 | $11 |
| Lactulose | 15 | $266 | $18 |
| Clonidine | 33 | $214 | $6 |
| Carvedilol | 36 | $192 | $5 |
| Potassium Chloride | 18 | $185 | $10 |
| Metoprolol | 25 | $136 | $5 |
| Hydrochlorothiazide | 22 | $106 | $5 |
| Minoxidil | 16 | $77 | $5 |
Year by year
| 2024 | 1,245 | 211 | 0% (0) | 9% | $268,296 |
| 2023 | 1,030 | 186 | 0% (0) | 13% | $227,416 |
| 2022 | 896 | 144 | 0% (0) | 9% | $163,866 |
| 2021 | 1,013 | 167 | None | 11% | $119,271 |
| 2020 | 1,221 | 179 | None | 11% | $163,215 |
| 2019 | 905 | 134 | 0% (0) | 13% | $134,146 |
| 2018 | 178 | 61 | 0% (0) | 18% | $20,879 |
| 2017 | 55 | 22 | 0% (0) | None | $1,187 |
| 2016 | 173 | 48 | 0% (0) | None | $16,341 |
| 2015 | 209 | 47 | 0% (0) | None | $17,016 |
| 2014 | 201 | 30 | None | None | $11,215 |
| 2013 | 45 | 13 | 0% (0) | 31% | $1,877 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Velphoro | 23 | $95,185 | $4,138 |
| Renvela | 14 | $39,328 | $2,809 |
| Sevelamer Carbonate | 34 | $24,351 | $716 |
| Lokelma | 15 | $13,695 | $913 |
| Calcium Acetate | 79 | $7,905 | $100 |
| Calcitriol | 109 | $4,044 | $37 |
| Losartan | 112 | $2,241 | $20 |
| Hydralazine | 68 | $1,928 | $28 |
| Nifedipine Er | 26 | $1,848 | $71 |
| Prosol | 12 | $1,593 | $133 |
| Amlodipine Besylate | 104 | $1,351 | $13 |
| Furosemide | 99 | $1,040 | $11 |
| Lisinopril | 54 | $948 | $18 |
| Clonidine | 32 | $607 | $19 |
| Chlorthalidone | 17 | $421 | $25 |
| Carvedilol | 31 | $417 | $13 |
| Metoprolol | 20 | $383 | $19 |
| Metoprolol | 14 | $326 | $23 |
| Prednisone | 19 | $236 | $12 |
| Minoxidil | 12 | $102 | $9 |
| Hydrochlorothiazide | 11 | $35 | $3 |
2022: 19 drugs
| Velphoro | 17 | $60,611 | $3,565 |
| Sevelamer Carbonate | 68 | $40,155 | $591 |
| Renvela | 17 | $32,968 | $1,939 |
| Calcium Acetate | 44 | $3,802 | $86 |
| Calcitriol | 101 | $3,175 | $31 |
| Nifedipine Er | 14 | $1,464 | $105 |
| Hydralazine | 58 | $1,365 | $24 |
| Losartan | 124 | $1,362 | $11 |
| Furosemide | 99 | $811 | $8 |
| Chlorthalidone | 17 | $649 | $38 |
| Amlodipine Besylate | 70 | $499 | $7 |
| Lisinopril | 38 | $414 | $11 |
| Potassium Chloride | 14 | $379 | $27 |
| Clonidine | 20 | $337 | $17 |
| Metoprolol | 20 | $241 | $12 |
| Prednisone | 18 | $228 | $13 |
| Carvedilol | 22 | $129 | $6 |
| Spironolactone | 15 | $128 | $9 |
| Minoxidil | 12 | $108 | $9 |
2021: 21 drugs
| Sevelamer Carbonate | 67 | $36,370 | $543 |
| Renvela | 11 | $12,821 | $1,166 |
| Tacrolimus | 11 | $5,895 | $536 |
| Cinacalcet | 12 | $3,913 | $326 |
| Calcitriol | 98 | $2,765 | $28 |
| Calcium Acetate | 34 | $2,655 | $78 |
| Nifedipine Er | 25 | $1,370 | $55 |
| Losartan | 101 | $1,237 | $12 |
| Hydralazine | 45 | $1,103 | $25 |
| Chlorthalidone | 37 | $1,085 | $29 |
| Furosemide | 136 | $909 | $7 |
| Lisinopril | 62 | $512 | $8 |
| Amlodipine Besylate | 48 | $464 | $10 |
| Prednisone | 33 | $454 | $14 |
| Carvedilol | 30 | $397 | $13 |
| Potassium Citrate Er | 11 | $341 | $31 |
| Atorvastatin | 19 | $233 | $12 |
| Potassium Chloride | 13 | $223 | $17 |
| Clonidine | 19 | $206 | $11 |
| Spironolactone | 15 | $196 | $13 |
| Tamsulosin | 13 | $139 | $11 |
2020: 24 drugs
| Renvela | 23 | $54,245 | $2,358 |
| Cinacalcet | 25 | $20,016 | $801 |
| Sevelamer Carbonate | 62 | $15,805 | $255 |
| Calcium Acetate | 44 | $4,116 | $94 |
| Calcitriol | 95 | $2,375 | $25 |
| Nifedipine Er | 46 | $1,845 | $40 |
| Hydralazine | 69 | $1,200 | $17 |
| Bumetanide | 11 | $1,056 | $96 |
| Losartan | 92 | $636 | $7 |
| Furosemide | 132 | $598 | $5 |
| Spironolactone | 24 | $563 | $23 |
| Chlorthalidone | 20 | $550 | $27 |
| Amlodipine Besylate | 95 | $548 | $6 |
| Lisinopril | 92 | $490 | $5 |
| Metoprolol | 16 | $394 | $25 |
| Clonidine | 51 | $386 | $8 |
| Potassium Citrate Er | 12 | $379 | $32 |
| Prednisone | 40 | $363 | $9 |
| Carvedilol | 40 | $308 | $8 |
| Allopurinol | 24 | $177 | $7 |
| Tamsulosin | 18 | $148 | $8 |
| Atorvastatin | 13 | $114 | $9 |
| Metoprolol | 16 | $95 | $6 |
| Hydrochlorothiazide | 13 | $57 | $4 |
2019: 18 drugs
| Renvela | 23 | $37,838 | $1,645 |
| Sensipar | 13 | $32,912 | $2,532 |
| Sevelamer Carbonate | 46 | $22,374 | $486 |
| Calcium Acetate | 40 | $3,400 | $85 |
| Nifedipine Er | 62 | $2,491 | $40 |
| Calcitriol | 68 | $2,021 | $30 |
| Chlorthalidone | 39 | $1,095 | $28 |
| Bumetanide | 12 | $732 | $61 |
| Losartan | 76 | $575 | $8 |
| Hydralazine | 29 | $501 | $17 |
| Amlodipine Besylate | 52 | $463 | $9 |
| Carvedilol | 52 | $428 | $8 |
| Clonidine | 46 | $375 | $8 |
| Furosemide | 83 | $308 | $4 |
| Lisinopril | 49 | $254 | $5 |
| Midodrine | 15 | $246 | $16 |
| Spironolactone | 24 | $244 | $10 |
| Metoprolol | 20 | $80 | $4 |
2018: 5 drugs
| Chlorthalidone | 11 | $384 | $35 |
| Lisinopril | 18 | $96 | $5 |
| Furosemide | 26 | $91 | $3 |
| Losartan | 11 | $86 | $8 |
| Carvedilol | 11 | $68 | $6 |
2015: 4 drugs
| Losartan | 14 | $179 | $13 |
| Lisinopril | 23 | $123 | $5 |
| Amlodipine Besylate | 15 | $112 | $7 |
| Furosemide | 13 | $33 | $3 |
2014: 3 drugs
| Galantamine Hbr | 11 | $1,174 | $107 |
| Atorvastatin | 11 | $245 | $22 |
| Furosemide | 13 | $29 | $2 |
Money from drug and device companies
$232 in 2025
| 2025 | 4 | 8 | None | $232 |
| 2024 | 2 | 7 | None | $330 |
| 2023 | 4 | 5 | None | $402 |
| 2022 | 3 | 4 | None | $158 |
| 2021 | 2 | 2 | None | $168 |
| 2019 | 3 | 3 | None | $280 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| NxStage Medical | Nxstage System One | $92 | 2 payments
|
| Amgen | Tavneos | $76 | 2 payments
|
| Collegium Pharmaceutical | Belbuca | $51 | 3 payments
|
| Novartis Pharmaceuticals | Vanrafia | $14 | 1 payment
|
See all 8 published payments
| Collegium Pharmaceutical | Meals · 2025-12-02 | Belbuca | $17 |
| Collegium Pharmaceutical | Meals · 2025-10-15 | Belbuca | $18 |
| Amgen | Meals · 2025-08-21 | Tavneos | $59 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Vanrafia | $14 |
| Collegium Pharmaceutical | Meals · 2025-07-24 | Belbuca | $16 |
| Amgen | Meals · 2025-04-11 | Krystexxa | $17 |
| NxStage Medical | Meals · 2025-03-05 | Nxstage System One | $67 |
| NxStage Medical | Meals · 2025-02-19 | Nxstage System One | $25 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $330
| Janssen Pharmaceuticals | Xarelto | $201 | 5 payments
|
| Amgen | Tavneos | $129 | 2 payments
|
2023: $402
| Calliditas Therapeutics US | Tarpeyo | $132 | 1 payment
|
| Alexion Pharmaceuticals | None | $125 | 1 payment
|
| Fresenius USA Marketing | Korsuva | $111 | 1 payment
|
| Daiichi Sankyo | Injectafer | $33 | 2 payments
|
2022: $158
| Aurinia Pharma U.S. | Lupkynis | $124 | 2 payments
|
| Daiichi Sankyo | Injectafer | $21 | 1 payment
|
| GlaxoSmithKline | Benlysta | $13 | 1 payment
|
2021: $168
| Amgen | None | $100 | 1 payment
|
| Acerta Pharma | None | $68 | 1 payment
|
2019: $280
| Baxter Healthcare | Renal - Pd | $102 | 1 payment
|
| Relypsa | Veltassa | $89 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $89 | 1 payment
|
Professional record
- NPI
- 1477996031
- Licence
- CA A152903California A152903: Current · expires 2027-11-30
- Trained
- Yale University School of Medicine, 2018 · 8 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 1111 Exposition Blvd Ste 300, Sacramento, CA, 95815
- NPI first listed
- 2013-04-14
- NPI last updated
- 2026-09-08
- NPI record certified
- 2026-09-08
This is when the NPI record was last certified, not a medical board exam.